Research study Program year 2025 Source: CMS Open Payments

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (Summit

ClinicalTrials.gov NCT04847557

Research payments

$4,334,189

262 payments

Through program year 2025, $4,334,189 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (Summit, across 262 payments.

Paid by (largest first)
Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
ClinicalTrials.gov
NCT04847557

By program year

4 rows
Year Kind Amount Payments
2025 Research $118,055 9
2024 Research $1,412,471 59
2022 Research $1,906,206 106
2021 Research $897,457 88

Breakdown

Who paid Research payments · program years 2021–2025
  1. Eli Lilly and Company $4,294,240 258 payments
  2. Eli Lilly Export S.A. Puerto Rico Branch $39,949 4 payments
Who received the money Research payments · program years 2021–2025
  1. Amicis Research Center Organisation paid for research $347,651 3 payments
  2. Cleveland Clinic Hospital Teaching hospital · OH $345,990 10 payments
  3. Excel Medical Clinical Trials, LLC Organisation paid for research $264,008 6 payments
  4. Medical University of South Carolina Organisation paid for research $239,064 6 payments
  5. Clearwater Cardiovascular Organisation paid for research $210,786 14 payments
  6. St Louis Heart and Vascular PC Organisation paid for research $208,538 3 payments
  7. Discoveresearch INC Organisation paid for research $162,141 5 payments
  8. Northwest Houston Clinical Research Pllc Organisation paid for research $150,591 4 payments
  9. Sherman Clinical Research LLC Organisation paid for research $134,630 4 payments
  10. Infinite Clinical Research INC Organisation paid for research $132,452 4 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record